Zhu, Tianxing
Hsu, Jessica C.
Guo, Jingpei
Chen, Weiyu
Cai, Weibo http://orcid.org/0000-0003-4641-0833
Wang, Kai
Funding for this research was provided by:
Natural Science Foundation of China (82101916)
Huadong MedicineJoint Funds of the Zhejiang Provincial Natural Science Foundation of China (LHDMZ22H300005)
Major project of Science and Technology Program of Jinhua, China (2022-3-039)
University of Wisconsin – Madison (P30 CA014520)
National Institutes of Health (T32 CA009206)
Article History
Received: 15 December 2022
Accepted: 25 February 2023
First Online: 16 March 2023
Declarations
:
: This article does not contain any studies with human participants or animals performed by any of the authors.
: Weibo Cai is a scientific advisor, stockholder, and grantee of Focus-X Therapeutics, Inc.; a consultant and grantee of Actithera, Inc.; a consultant of Rad Source Technologies, Inc.; a scientific advisor of Portrai, Inc.; and a scientific advisor and stockholder rTR Technovation Corporation. All other authors declare no conflict of interest.